These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 12034949

  • 1. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.
    Huber W, Ilgmann K, Page M, Hennig M, Schweigart U, Jeschke B, Lutilsky L, Weiss W, Salmhofer H, Classen M.
    Radiology; 2002 Jun; 223(3):772-9. PubMed ID: 12034949
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency.
    Huber W, Schipek C, Ilgmann K, Page M, Hennig M, Wacker A, Schweigart U, Lutilsky L, Valina C, Seyfarth M, Schömig A, Classen M.
    Am J Cardiol; 2003 May 15; 91(10):1157-62. PubMed ID: 12745095
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
    Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, Wang A, Chu AA, Schaer GL, Stevens M, Wilensky RL, O'Neill WW, CONTRAST Investigators.
    JAMA; 2003 Nov 05; 290(17):2284-91. PubMed ID: 14600187
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of theophylline in prevention of radiocontrast media-induced nephropathy.
    Malhis M, Al-Bitar S, Al-Deen Zaiat K.
    Saudi J Kidney Dis Transpl; 2010 Mar 05; 21(2):276-83. PubMed ID: 20228513
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduced incidence of radiocontrast-induced nephropathy in ICU patients under theophylline prophylaxis: a prospective comparison to series of patients at similar risk.
    Huber W, Jeschke B, Page M, Weiss W, Salmhofer H, Schweigart U, Ilgmann K, Reichenberger J, Neu B, Classen M.
    Intensive Care Med; 2001 Jul 05; 27(7):1200-9. PubMed ID: 11534569
    [Abstract] [Full Text] [Related]

  • 11. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.
    Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W.
    N Engl J Med; 2000 Jul 20; 343(3):180-4. PubMed ID: 10900277
    [Abstract] [Full Text] [Related]

  • 12. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, Gelormini JL, Labinaz M, Moreyra AE, Investigators of the CARE Study.
    Circulation; 2007 Jun 26; 115(25):3189-96. PubMed ID: 17562951
    [Abstract] [Full Text] [Related]

  • 13. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
    Mahesh B, Yim B, Robson D, Pillai R, Ratnatunga C, Pigott D.
    Eur J Cardiothorac Surg; 2008 Mar 26; 33(3):370-6. PubMed ID: 18243724
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients.
    Marenzi G, Lauri G, Campodonico J, Marana I, Assanelli E, De Metrio M, Grazi M, Veglia F, Fabbiocchi F, Montorsi P, Bartorelli AL.
    Am J Med; 2006 Feb 26; 119(2):155-62. PubMed ID: 16443418
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
    Drager LF, Andrade L, Barros de Toledo JF, Laurindo FR, Machado César LA, Seguro AC.
    Nephrol Dial Transplant; 2004 Jul 26; 19(7):1803-7. PubMed ID: 15128882
    [Abstract] [Full Text] [Related]

  • 20. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Spargias K, Alexopoulos E, Kyrzopoulos S, Iokovis P, Greenwood DC, Manginas A, Voudris V, Pavlides G, Buller CE, Kremastinos D, Cokkinos DV.
    Circulation; 2004 Nov 02; 110(18):2837-42. PubMed ID: 15492300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.